Chivonne Moodley Selected Research

Cytokines

12/2019

Compromised Metabolic Reprogramming Is an Early Indicator of CD8+ T Cell Dysfunction during Chronic Mycobacterium tuberculosis Infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chivonne Moodley Research Topics

Disease

9	Tuberculosis (Tuberculoses) 01/2023 - 01/2015
5	Infections 05/2022 - 01/2018
1	Granuloma 01/2023
1	Hypoxia (Hypoxemia) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Viremia 01/2022
1	COVID-19 07/2021
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2018
1	Leprosy (Hansen's Disease) 01/2017
1	Body Weight (Weight, Body) 01/2015
1	Meningococcal Infections 05/2014

Drug/Important Bio-Agent (IBA)

4	Clofazimine (Lamprene)FDA Link 01/2018 - 01/2015
2	AerosolsIBA 01/2022 - 01/2018
1	DioxygenasesIBA 01/2023
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2023
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 05/2022
1	C-Reactive ProteinIBA 05/2022
1	GlobulinsIBA 05/2022
1	Serum AlbuminIBA 05/2022
1	InterferonsIBA 01/2022
1	SuspensionsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 07/2021
1	CytokinesIBA 12/2019
1	Indicators and Reagents (Reagents)IBA 12/2019
1	Interleukin-6 (Interleukin 6)IBA 05/2014

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2023 - 01/2016
1	Euthanasia (Mercy Killing) 01/2022
1	Therapeutics 01/2022
1	Aftercare (After-Treatment) 01/2016